Consumer Brands Giant Helen of Troy Faces Lawsuit Over Misleading Forecasts
New York, Monday, 6 July 2026.
Following massive earnings drops of up to 60 percent, consumer goods giant Helen of Troy faces investor lawsuits alleging it hid critical failures in its cost-saving restructuring plan.
Legal Battles and the Fallout of Project Pegasus
The legal challenges for consumer products company Helen of Troy Limited (NASDAQ: HELE) have intensified as multiple prominent law firms initiate securities class action lawsuits on behalf of damaged investors [1][2][3]. On July 5, 2026, New York-based Pomerantz LLP issued a reminder to shareholders regarding an ongoing class action lawsuit alleging securities fraud and unlawful business practices [1]. This development was echoed on the same day by Bronstein, Gewirtz & Grossman, LLC, which filed a similar action in New York [2], following a July 2, 2026, announcement by San Diego-based Robbins LLP [3]. The litigation collectively covers a class period spanning from April 24, 2024, to October 8, 2025, during which investors purchased HELE securities under allegedly false pretenses [2][3].
At the heart of the litigation are allegations that Helen of Troy made materially false and misleading statements regarding its highly publicized cost-saving initiative, “Project Pegasus” [2][3]. The complaints allege that the company hid significant operational hurdles, specifically undisclosed “implementation hiccups” occurring at its central distribution center in Tennessee [2]. Furthermore, the lawsuits assert that Helen of Troy lacked the necessary budget and resources to meet its stated cost-saving goals, despite public assurances that the project was moving forward and simplifying its supplier base [2][3].
A Timeline of Financial Disappointments
The financial cracks first began to show publicly on July 9, 2024, when Helen of Troy reported a staggering 49% year-over-year decrease in earnings per share (EPS) and reduced its full-year revenue outlook by more than 20% [1]. This disappointing update immediately shook market confidence, causing the company’s stock price to plummet by 28% [1]. However, the financial distress deepened significantly in the following fiscal year. On July 10, 2025, the company reported an 11% year-over-year decline in first-quarter net sales, a nearly 60% drop in adjusted EPS, and a massive $414.4 million goodwill impairment [1][3]. In response to this news, the stock price fell by $7.04, representing a drop of 22.7% [3] or 23% according to alternative market tracking [1].
The downward trajectory continued into the second quarter of fiscal 2026. On October 9, 2025, Helen of Troy reported an 8.9% year-over-year quarterly sales decline alongside a 51% drop in adjusted EPS [1][3]. This announcement triggered yet another sharp market reaction, sending the stock price down by $6.90, which translated to a 25% drop [1][3]. Across the disclosures on July 10, 2025, and October 9, 2025, the stock price suffered a combined drop of $13.94 per share [3]. These sequential financial misses devastated shareholder value, providing the empirical foundation for the current wave of legal actions [1][2][3].
Corporate Restructuring and the Road Ahead
The internal operational issues behind these poor financial results were eventually acknowledged by the company’s own leadership. Interim CEO and CFO Brian Grass admitted that the company had become “too complicated and lost focus,” which “created unnecessary sprawl” and left the organization “scattered in terms of priorities” [3]. These internal complications directly impeded the execution of Project Pegasus, resulting in delayed savings and operational inefficiencies at the Tennessee distribution facility [2][3]. This stands in stark contrast to previous corporate communications where management claimed that Project Pegasus continued to move forward with good progress on reducing costs [3].
As the legal process moves forward, affected shareholders have a limited window to assert their rights. The law firms involved have reminded investors that the deadline to apply to the court to be appointed as Lead Plaintiff is August 3, 2026 [1][2][3]. This deadline represents a critical milestone for institutional and retail investors seeking to recoup losses stemming from the alleged corporate misconduct [1][2]. In the meantime, the firms continue to compile claims on a contingency fee basis, ensuring that legal fees are only recovered upon a successful litigation outcome [2][3].